GlassScriptPhysician profile
Ali Zahalka
NPI 1720584741
$5,183.74
in general payments reported to CMS, 2019-2025
10 companies · $832 in 2025
The $832 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,351 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,336 · Food and Beverage: $1,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,336.00 |
| Food and Beverage | $1,847.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $3,888.00 | 2024 | |
| Dendreon Pharmaceuticals LLC | $291.48 | 2025 | Provenge |
| Boston Scientific Corporation | $174.61 | 2024 | Ams 800 Artificial Urinary Sphincter |
| Coloplast Corp | $167.88 | 2024 | |
| Janssen Scientific Affairs, LLC | $140.02 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.25 | 2025 | |
| Progenics Pharmaceuticals, INC. | $130.43 | 2025 | |
| Myriad Genetic Laboratories, INC. | $120.79 | 2024 | Prolaris |
| Photocure INC | $105.03 | 2025 | Cysview |
| Cook Medical LLC | $34.25 | 2025 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Zahalka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.